115 related articles for article (PubMed ID: 6207116)
1. Evaluation of AFP glycosylation heterogeneity in cancer patients with AFP-producing tumors.
Vessella RL; Santrach MA; Bronson D; Smith CJ; Klicka MJ; Lange PH
Int J Cancer; 1984 Sep; 34(3):309-14. PubMed ID: 6207116
[TBL] [Abstract][Full Text] [Related]
2. Tissue alpha-fetoprotein and human chorionic gonadotrophin in non-seminomatous testicular tumours. A comparative study with serum levels.
Altug MU; Akdas A; Ruacan S; Ozen AH; Remzi D
Br J Urol; 1987 May; 59(5):458-62. PubMed ID: 2439163
[TBL] [Abstract][Full Text] [Related]
3. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
Javadpour N; McIntire KR; Waldmann TA
Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
[TBL] [Abstract][Full Text] [Related]
4. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
[TBL] [Abstract][Full Text] [Related]
5. Tumor markers in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):117-28. PubMed ID: 6170952
[TBL] [Abstract][Full Text] [Related]
6. Alpha-foetoprotein heterogeneity: what is its value in managing patients with germ cell tumours?
de Takats PG; Jones SR; Penn R; Cullen MH
Clin Oncol (R Coll Radiol); 1996; 8(5):323-6. PubMed ID: 8934053
[TBL] [Abstract][Full Text] [Related]
7. Lectin-reactive alpha-fetoprotein (AFP-L3%) curability and prediction of clinical course after treatment of non-seminomatous germ cell tumors.
Kamoto T; Satomura S; Yoshiki T; Okada Y; Henmi F; Nishiyama H; Kobayashi T; Terai A; Habuchi T; Ogawa O
Jpn J Clin Oncol; 2002 Nov; 32(11):472-6. PubMed ID: 12499420
[TBL] [Abstract][Full Text] [Related]
8. The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis.
Willemse PH; Sleijfer DT; Schraffordt Koops H; De Bruijn HW; Oosterhuis JW; Brouwers TM; Ockhuizen T; Marrink J
Oncodev Biol Med; 1981; 2(1-2):129-34. PubMed ID: 6170953
[TBL] [Abstract][Full Text] [Related]
9. Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.
Nazeer T; Ro JY; Amato RJ; Park YW; Ordonez NG; Ayala AG
Oncol Rep; 1998; 5(6):1425-9. PubMed ID: 9769381
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
11. The value of serial measurement of both human chorionic gonadotropin and alpha-fetoprotein for monitoring germinal cell tumors.
Perlin E; Engeler JE; Edson M; Karp D; McIntire KR; Waldmann TA
Cancer; 1976 Jan; 37(1):215-9. PubMed ID: 55299
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
Stevens MJ; Norman AR; Dearnaley DP; Horwich A
J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
[TBL] [Abstract][Full Text] [Related]
13. [An autopsy case of double cancer (Hepatocellular carcinoma and mixed germ cell tumor of the testis)--significance of alpha-fetoprotein and human chorionic gonadotropin as tumor markers].
Yamauchi M; Yoshigoe F; Mera F; Ogura K; Kameda H; Nakada J; Takasaka S; Machida T; Fukunaga M
Gan No Rinsho; 1983 Apr; 29(4):A-22, 349-52. PubMed ID: 6190021
[TBL] [Abstract][Full Text] [Related]
14. Alpha-1 antitrypsin (AAT) and alphafoetoprotein (AFP) in sera of patients with germ-cell neoplasms: value as tumour markers in patients with endodermal sinus tumour (yolk sac tumour).
Talerman A; Haije WG; Baggerman L
Int J Cancer; 1977 Jun; 19(6):741-6. PubMed ID: 68937
[TBL] [Abstract][Full Text] [Related]
15. Serial monitoring of serum alpha-fetoprotein and chorionic gonadotropin in males with germ cell tumors.
Thompson DK; Haddow JE
Cancer; 1979 May; 43(5):1820-9. PubMed ID: 87255
[No Abstract] [Full Text] [Related]
16. [Limitations of tumor marker surveillance after chemotherapy in advanced non-seminomatous testicular tumors].
Behrendt H; Ringert RH; Pfeiffer R; Homann W; Hartung R
Urol Int; 1983; 38(5):307-9. PubMed ID: 6195793
[TBL] [Abstract][Full Text] [Related]
17. [Importance of the intracellular detection of alpha-fetoprotein and beta-human chorionic gonadotropin in a testicular tumor using immunoperoxidase].
Schwarz HP; Susani M; Kratzik C; Studler G; Krisch K; Aiginger P
Wien Klin Wochenschr; 1984 Mar; 96(6):230-4. PubMed ID: 6204462
[TBL] [Abstract][Full Text] [Related]
18. Biologic tumor markers in management of testicular and bladder cancer.
Javadpour N
Urology; 1978 Aug; 12(2):177-83. PubMed ID: 80871
[TBL] [Abstract][Full Text] [Related]
19. Applications of biologic tumor markers in testicular cancer.
Javadpour N
Cancer Treat Rep; 1979; 63(9-10):1643-7. PubMed ID: 91433
[TBL] [Abstract][Full Text] [Related]
20. [Serum AFP subfractions in patients with hepatic cancer or germ cell tumor of the gonads].
Ishiguro T; Fukui M; Sugitachi I; Sakaguchi H; Itani S
Gan No Rinsho; 1985 May; 31(6 Suppl):611-5. PubMed ID: 2411963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
